Recent Finacing
Recent Raise
Alpha Biopharma is a Shanghai-based clinical-stage biopharma developing AZD3759, a small-molecule EGFR tyrosine kinase inhibitor for EGFR-mutant NSCLC with CNS metastases, running a global Phase II.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
